Drug intelligence / Profile preview

diclofenac diethylamine + methyl salicylate + menthol + linseed oil

Development stage
Unknown
Lead developer
BLS Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

Relifast is a topical analgesic spray developed by BLS Pharma, primarily indicated for the rapid relief of musculoskeletal pain, including muscle aches, joint pain, backache, sprains, and strains. It is a multi-ingredient small molecule formulation containing diclofenac diethylamine, methyl salicylate, menthol, and linseed oil. Diclofenac diethylamine is a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation by inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, thereby decreasing prostaglandin synthesis. Methyl salicylate and menthol act as counter-irritants; menthol stimulates TRPM8 receptors to produce a cooling sensation, while methyl salicylate provides a warming effect, together modulating pain perception through the gate control theory and improving local circulation. Linseed oil, rich in alpha-linolenic acid, provides additional anti-inflammatory properties and aids in the penetration of the active ingredients. The spray delivery system is designed for fast absorption and convenient application to targeted areas.

Brand names
Relifast
Other names
Relifast Spray
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac diethylamine + methyl salicylate + menthol + linseed oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac diethylamine + methyl salicylate + menthol + linseed oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call